CNS Tumor Clinical Trial
Official title:
Vigilant ObservatIon of GlIadeL WAfer ImplaNT (VIGILANT) Registry: A Multicenter, Observational Registry to Collect Information on the Safety and Effectiveness of Gliadel® Wafer (Carmustine Implant) Used in Usual Medical Practice
This is a prospective, observational registry in patients who have been prescribed Gliadel Wafer by the physician as part of usual care.
This is a prospective, observational registry in patients who have been prescribed Gliadel Wafer by the physician as part of usual care. Data will be collected on the safety and effectiveness of treatment with Gliadel Wafer perioperatively and ongoing during regular office visits up to 3-years. Patients enrolled in this registry will be asked to complete a questionnaire (Functional Assessment of Cancer Therapy-Brain [FACT-Br]) about their well-being and clinicians will complete the Karnofsky Performance Status (KPS) during office visits. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT06036394 -
Artificial Intelligence in CNS Radiation Oncology
|
||
| Withdrawn |
NCT05222165 -
Study With Infigratinib in Subjects With Advanced Solid and CNS Tumors or Recurrent or Progressive Low-Grade Glioma With Selected FGFR1-3 Alterations
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03838042 -
INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05300113 -
Artificial Intelligence Neuropathologist
|
||
| Completed |
NCT04334239 -
Effectiveness of Care in Certified Cancer Centres in Germany
|
||
| Completed |
NCT03434262 -
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
|
Phase 1 | |
| Withdrawn |
NCT05952687 -
Trial of Idasanutlin and Selinexor Therapy for Children With Progressive/Relapsed AT/RT or Extra-CNS Malignant Rhabdoid Tumors
|
Phase 1 | |
| Terminated |
NCT02988726 -
Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma
|
Phase 2 | |
| Recruiting |
NCT06322342 -
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
|
Phase 2 | |
| Not yet recruiting |
NCT06441331 -
Phase I Trial to Determine the Dose and Evaluate the PK of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
|
Phase 1 | |
| Recruiting |
NCT04706676 -
Integrative Neuromuscular Training in Adolescents and Children Treated for Cancer
|
N/A | |
| Recruiting |
NCT04773782 -
A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT04023669 -
Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors
|
Phase 1 | |
| Recruiting |
NCT05982691 -
Development of Asian Consortium for Data Collection and Clinical Trial of CNS Tumors
|
||
| Recruiting |
NCT04732065 -
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
|
Phase 1 | |
| Recruiting |
NCT05480904 -
Characterizing Sleep Among Long-term Survivors of Childhood Cancer
|